share_log
Moomoo 24/7 ·  Apr 18 06:30
Cerevel Therapeutics Holdings Inc - Results From Tavapadon Phase 3 Monotherapy Trials (Tempo-1 and Tempo-2) Are Expected in Second Half of 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment